The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Inflammation and cancer: how friendly is the relationship for cancer patients?
Open accessAbstract
Evidence has emerged in the last two decades that at the molecular level most chronic diseases, including cancer, are caused by a dysregulated inflammatory response. The identification of transcription factors such as NF-kB, AP-1 and STAT3 and their gene products such as tumor necrosis factor, interleukin-1, interleukin-6, chemokines, cyclooxygenase-2, 5 lipooxygenase, matrix metalloproteases, and vascular endothelial growth factor, adhesion molecules and others have provided the molecular basis for the role of inflammation in cancer. These inflammatory pathways are activated by tobacco, stress, dietary agents, obesity, alcohol, infectious agents, irradiation, and environmental stimuli, which together account for as much as 95% of all cancers. These pathways have been implicated in transformation, survival, proliferation, invasion, angiogenesis, metastasis, chemoresistance, and radioresistance of cancer, so much so that survival and proliferation of most types of cancer stem cells themselves appear to be dependent on the activation of these inflammatory pathways. Most of this evidence, however, is from preclinical studies. Whether these pathways have any role in prevention, progression, diagnosis, prognosis, recurrence or treatment of cancer in patients, is the topic of discussion of this review. We present evidence that inhibitors of inflammatory biomarkers may have a role in both prevention and treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Self-citationKucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene
Boehm, J. S., Zhao, J. J., Yao, J., Kim, S. Y., Firestein, R., Dunn, I. F., Sjostrom, S. K., Garraway, L. A., Weremowicz, S., Richardson, A. L., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.052 · Cited by 617
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 597
Wilson, K. T., Fu, S., Ramanujam, K. S., & Meltzer, S. J. (1998) · PubMed · Cited by 591
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity
Fujioka, S., Niu, J., Schmidt, C., Sclabas, G. M., Peng, B., Uwagawa, T., Li, Z., Evans, D. B., Abbruzzese, J. L., & Chiao, P. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7806-7819.2004 · Cited by 471
NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., & Iglehart, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403621101 · Cited by 447
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER
Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., & Fiers, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91850-2 · Cited by 418
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Khuri, F. R., Wu, H., Lee, J. J., Kemp, B. L., Lotan, R., Lippman, S. M., Feng, L., Hong, W. K., & Xu, X. C. (2001) · PubMed · Cited by 406
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia
Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B., Spaulding, C., Macaroun, S., Alegre, M.-L., et al. (2007) · Nature Medicine · doi:10.1038/nm1524 · Cited by 335
Expression of cyclooxygenase-2 in prostate carcinoma
Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T., & Wada, S. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<589::aid-cncr14>3.0.co;2-c · Cited by 335
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono, T., Tofilon, P. J., Bruner, J. M., Owolabi, O., & Lang, F. F. (2001) · PubMed · Cited by 332
Bharti, A. C., Shishodia, S., Reuben, J. M., Weber, D., Alexanian, R., Raj-Vadhan, S., Estrov, Z., Talpaz, M., & Aggarwal, B. B. (2004) · Blood · doi:10.1182/blood-2003-06-2151 · Cited by 318
Self-citationHigh-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
Bargou, R., Leng, C., Krappmann, D., Emmerich, F., Mapara, M., Bommert, K., Royer, H., Scheidereit, C., & Dorken, B. (1996) · Blood · doi:10.1182/blood.v87.10.4340.bloodjournal87104340 · Cited by 309
Zhang, G.-J., & Adachi, I. (1999) · PubMed · Cited by 306
Kanda, N., Seno, H., Konda, Y., Marusawa, H., Kanai, M., Nakajima, T., Kawashima, T., Nanakin, A., Sawabu, T., Uenoyama, Y., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207606 · Cited by 302
Masunaga, R., Kohno, H., Dhar, D. K., Ohno, S., Shibakita, M., Kinugasa, S., Yoshimura, H., Tachibana, M., Kubota, H., & Nagasue, N. (2000) · PubMed · doi:10.11501/3179825 · Cited by 290
Kallakury, B., Karikehalli, S., Haholu, A., Sheehan, C. E., Azumi, N., & Ross, J. S. (2001) · PubMed · Cited by 280
Costa, C., Soares, R., Reis-Filho, J. S., Leitao, D., Amendoeira, I., & Schmitt, F. C. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.429 · Cited by 275
Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Soumaoro, L. T., Uetake, H., Higuchi, T., Takagi, Y., Enomoto, M., & Sugihara, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0653 · Cited by 250
Frank, D. A., Mahajan, S., & Ritz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119869 · Cited by 239
Kossakowska, A. E., Edwards, D. R., Prusinkiewicz, C., Zhang, M. C., Guo, D., Urbanski, S. J., Grogan, T., Marquez, L. A., & Janowska-Wieczorek, A. (1999) · Blood · doi:10.1182/blood.v94.6.2080 · Cited by 230
Haura, E. B., Zheng, Z., Song, L., Cantor, A., & Bepler, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0827 · Cited by 223
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
Salvucci, O., Bouchard, A., Baccarelli, A., Deschenes, J., Sauter, G., Simon, R., Bianchi, R., & Basik, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9121-8 · Cited by 221
Rhodus, N. L., Ho, V., Miller, C. S., Myers, S., & Ondrey, F. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.10.003 · Cited by 220
O'Riordan, J. M., Abdel-latif, M. M., Ravi, N., McNamara, D., Byrne, P. J., McDonald, G. S. A., Keeling, P. W. N., Kelleher, D., & Reynolds, J. V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41338.x · Cited by 220
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
Kaifi, J. T., Yekebas, E. F., Schurr, P., Obonyo, D., Wachowiak, R., Busch, P., Heinecke, A., Pantel, K., & Izbicki, J. R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji431 · Cited by 217
Birnie, R., Bryce, S. D., Roome, C., Dussupt, V., Droop, A., Lang, S. H., Berry, P. A., Hyde, C. F., Lewis, J. L., Stower, M. J., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-5-r83 · Cited by 212
Murphy, C., McGurk, M., Pettigrew, J., Santinelli, A., Mazzucchelli, R., Johnston, P. G., Montironi, R., & Waugh, D. J. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1518 · Cited by 211
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Ogino, S., Kirkner, G. J., Nosho, K., Irahara, N., Kure, S., Shima, K., Hazra, A., Chan, A. T., Dehari, R., Giovannucci, E. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1841 · Cited by 209
Crazzolara, R., Kreczy, A., Mann, G., Heitger, A., Eibl, G., Fink, F., Möhle, R., & Meister, B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03164.x · Cited by 204
Li, Y.-H., Hu, C.-F., Shao, Q., Huang, M.-Y., Hou, J.-H., Xie, D., Zeng, Y.-X., & Shao, J.-Y. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-1 · Cited by 204
Constitutive activation of nuclear factor ?B in hepatocellular carcinoma
Tai, D.-I., Tsai, S.-L., Chang, Y.-H., Huang, S.-N., Chen, T.-C., Chang, K. S. S., & Liaw, Y.-F. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2274::aid-cncr16>3.0.co;2-2 · Cited by 201
Voorzanger‐Rousselot, N., Touitou, R., Garcia, E., Delecluse, H., Rousset, F., Joab, I., Favrot, M., & Blay, J. (1996) · PubMed · Cited by 192
Ferrajoli, A., Keating, M. J., Manshouri, T., Giles, F. J., Dey, A., Estrov, Z., Koller, C. A., Kurzrock, R., Thomas, D. A., Faderl, S., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1215.h81602001215_1215_1219 · Cited by 191
Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions
Tang, X., Liu, D., Shishodia, S., Ozburn, N., Behrens, C., Lee, J. J., Hong, W. K., Aggarwal, B. B., & Wistuba, I. I. (2006) · Cancer · doi:10.1002/cncr.22315 · Cited by 190
Self-citationExpression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma
Denkert, C., Köbel, M., Pest, S., Koch, I., Berger, S., Schwabe, M., Siegert, A., Reles, A., Klosterhalfen, B., & Hauptmann, S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64912-7 · Cited by 188
NF-kappa B genes have a major role in Inflammatory Breast Cancer
Lerebours, F., Vacher, S., Andrieu, C., Espie, M., Marty, M., Lidereau, R., & Bieche, I. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-41 · Cited by 186
Benekli, M., Xia, Z., Donohue, K. A., Ford, L. A., Pixley, L. A., Baer, M. R., Baumann, H., & Wetzler, M. (2002) · Blood · doi:10.1182/blood.v99.1.252 · Cited by 180
Wilborn, J., Bailie, M., Coffey, M., Burdick, M., Strieter, R., & Peters-Golden, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118612 · Cited by 176
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Cheng, W.-F., Chang, M.-C., Su, J.-L., & Hsieh, C.-Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204733 · Cited by 174
YUAN, A., YANG, P.-C., YU, C.-J., CHEN, W.-J., LIN, F.-Y., KUO, S.-H., & LUH, K.-T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2002108 · Cited by 173
Rhodus, N. L., Cheng, B., Myers, S., Bowles, W., Ho, V., & Ondrey, F. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.003 · Cited by 172
Ottaiano, A., Franco, R., Aiello Talamanca, A., Liguori, G., Tatangelo, F., Delrio, P., Nasti, G., Barletta, E., Facchini, G., Daniele, B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2142 · Cited by 171
Kinoshita, T., Ito, H., & Miki, C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990615)85:12<2526::aid-cncr6>3.0.co;2-3 · Cited by 169
NF- B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
Braun, T., Carvalho, G., Coquelle, A., Vozenin, M.-C., Lepelley, P., Hirsch, F., Kiladjian, J.-J., Ribrag, V., Fenaux, P., & Kroemer, G. (2005) · Blood · doi:10.1182/blood-2005-05-1989 · Cited by 166
The NFκB pathway and endocrine-resistant breast cancer
Zhou, Y., Eppenberger-Castori, S., Eppenberger, U., & Benz, C. C. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00977 · Cited by 166
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma
Seymour, J. F., Talpaz, M., Cabanillas, F., Wetzler, M., & Kurzrock, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.575 · Cited by 164
Shih, C.-H., Ozawa, S., Ando, N., Ueda, M., & Kitajima, M. (2000) · PubMed · Cited by 164
Ruíz-Ballesteros, E., Mollejo, M., Rodríguez, A., Camacho, F. I., Algara, P., Martínez, N., Pollán, M., Sánchez‐Aguilera, A., Menárguez, J., Campo, E., et al. (2005) · Blood · doi:10.1182/blood-2004-10-3898 · Cited by 161
Su, L., Zhang, J., Xu, H., Wang, Y., Chu, Y., Liu, R.-Z., & Xiong, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0537 · Cited by 159
Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]
Ludwig, H., Nachbaur, D., Fritz, E., Krainer, M., & Huber, H. (1991) · Blood · doi:10.1182/blood.v77.12.2794.2794 · Cited by 158
Ashizawa, T., Okada, R., Suzuki, Y., Takagi, M., Yamazaki, T., Sumi, T., Aoki, T., Ohnuma, S., & Aoki, T. (2005) · Gastric Cancer · doi:10.1007/s10120-005-0315-x · Cited by 158
Logan, R. M., Gibson, R. J., Sonis, S. T., & Keefe, D. M. K. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.04.011 · Cited by 157
Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder Carcinomas
Kömhoff, M., Guan, Y., Shappell, H. W., Davis, L. S., Jack, G. S., Shyr, Y., Koch, M. O., Shappell, S. B., & Breyer, M. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64513-0 · Cited by 149
Cytokine Network in Human Multiple Myeloma
Klein, B., & Bataille, R. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30344-7 · Cited by 145
Kassim, S. K., El-Salahy, E. M., Fayed, S. T., Helal, S. A., Helal, T., Azzam, E. E.-D., & Khalifa, A. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.014 · Cited by 144
Weichert, W., Boehm, M., Gekeler, V., Bahra, M., Langrehr, J. M., Neuhaus, P., Denkert, C., Imre, G., Weller, C., Hofmann, H.-P., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603878 · Cited by 143
Lessard, L., Bégin, L. R., Gleave, M. E., Mes‐Masson, A., & Fred Saad, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602796 · Cited by 140
Izzo, J. G., Malhotra, U., Wu, T., Ensor, J., Luthra, R., Lee, J. H., Swisher, S. G., Liao, Z. X., Chao, K. S. C., Hittelman, W. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8810 · Cited by 140
Self-citationExpression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
Yoshitake, N., Fukui, H., Yamagishi, H., Sekikawa, A. M., Fujii, S., Tomita, S., Ichikawa, K., Imura, J., Hiraishi, H., & Fujimori, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604363 · Cited by 138
Mishra, A., Bharti, A. C., Varghese, P., Saluja, D., & Das, B. C. (2006) · International Journal of Cancer · doi:10.1002/ijc.22262 · Cited by 137
Stat3 activation in prostatic carcinomas
Dhir, R., Ni, Z., Lou, W., DeMiguel, F., Grandis, J. R., & Gao, A. C. (2002) · The Prostate · doi:10.1002/pros.10079 · Cited by 137
Tumor iNOS predicts poor survival for stage III melanoma patients
Ekmekçioglu, S., Ellerhorst, J. A., Prieto, V. G., Johnson, M. M., Broemeling, L. D., & Grimm, E. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21767 · Cited by 135
Kodama, J., Hasengaowa, Kusumoto, T., Seki, N., Matsuo, T., Ojima, Y., Nakamura, K., Hongo, A., & Hiramatsu, Y. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl342 · Cited by 135
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer
Kang, H., Watkins, G., Douglas-Jones, A. G., Mansel, R. E., & Jiang, W. G. (2005) · The Breast · doi:10.1016/j.breast.2004.12.007 · Cited by 133
Du, Q., Zhang, X., Cardinal, J. S., Cao, Z., Guo, Z., Shao, L., & Geller, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0014 · Cited by 133
Kido, S., Kitadai, Y., Hattori, N., Haruma, K., Kido, T., Ohta, M., Tanaka, S., Yoshihara, M., Sumii, K., Ohmoto, Y., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00147-2 · Cited by 132
Fradet, V., Lessard, L., Bégin, L. R., Karakiewicz, P. I., Mes‐Masson, A., & Fred Saad, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0764 · Cited by 131
Zhou, Y., Eppenberger‐Castori, S., Marx, C., Yau, C. S. F., Scott, G. K., Eppenberger, U., & Benz, C. C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.006 · Cited by 127
Widespread CXCR4 Activation in Astrocytomas Revealed by Phospho-CXCR4-Specific Antibodies
Woerner, B. M., Warrington, N. M., Kung, A. L., Perry, A., & Rubin, J. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0847 · Cited by 127
Kim, J. G., Chae, Y. S., Sohn, S. K., Cho, Y. Y., Moon, J. H., Park, J. Y., Jeon, S. W., Lee, I. T., Choi, G., & Jun, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1537 · Cited by 126
Miyata, Y., Koga, S., Kanda, S., Nishikido, M., Hayashi, T., & Kanetake, H. (2003) · PubMed · Cited by 124
Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas
Martínez–Delgado, B., Cuadros, M., Honrado, E., de la Parte, A. R., Roncador, G., Alves, J., Castrillo, J. M., Rivas, C., Benitez, J. J., & and The Spanish Cooperative Group for the study of T-cell lymphomas (2005) · Leukemia · doi:10.1038/sj.leu.2403960 · Cited by 123
Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer
Rubie, C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i37.4996 · Cited by 121
Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma
Ma, X.-T., Wang, S., Ye, Y.-J., Du, R.-Y., Cui, Z.-R., & Somsouk, M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i11.1569 · Cited by 119
Miki, C., Konishi, N., Ojima, E., Hatada, T., Inoue, Y., & Kusunoki, M. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034556.48527.6e · Cited by 118
Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue
Jabs, W. J., Busse, M., Krüger, S., Jocham, D., Steinhoff, J., & Doehn, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00666.x · Cited by 117
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Khor, L.-Y., Bae, K., Pollack, A. S., Hammond, M. E., Grignon, D. J., Venkatesan, V., Rosenthal, S. A., Ritter, M. A., Sandler, H. M., Hanks, G. E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70280-2 · Cited by 117
Domenech, J. M. D., Mellado, B., Ferrer, B., Truan, D., Codony‐Servat, J., Sauleda, S., Alcover, J., Campo, E., Gascon, P., Rovira, A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602851 · Cited by 116
Kim, Y. B., Kim, G. E., Cho, N. H., Pyo, H. R., Shim, S. J., Chang, S. K., Park, H. C., Suh, C., Park, T. K., & Kim, B. (2002) · Cancer · doi:10.1002/cncr.10684 · Cited by 113
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma
Preti, H. A., Cabanillas, F., Talpaz, M., Tucker, S. L., Seymour, J. F., & Kurzrock, R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00002 · Cited by 112
de Bont, E. S. J. M., Rosati, S., Jacobs, S. C., Kamps, W. A., & Vellenga, E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02722.x · Cited by 111
Russell, H. V., Hicks, J. M., Okcu, M. F., & Nuchtern, J. G. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.06.019 · Cited by 111
Duncan, T. J., Al‐Attar, A., Rolland, P., Scott, I., Deen, S., Liu, D. T. Y., Spendlove, I., & Durrant, L. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1888 · Cited by 110
Deans, D. A. C., Wigmore, S. J., Gilmour, H. M., Paterson‐Brown, S., Ross, J. A., & Fearon, K. C. H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603446 · Cited by 110
Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer
Zhang, X., Huang, D.-P., Guo, G.-L., Chen, G.-R., Zhang, H.-X., Wan, L., & Chen, S.-Y. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-4 · Cited by 107
Kai, H., Kitadai, Y., Kodama, M., Cho, S., Kuroda, T., Ito, M., Tanaka, S., Ohmoto, Y., & Chayama, K. (2005) · PubMed · Cited by 106
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
Sharma, R., Zucknick, M., London, R. M., Kacevska, M., Liddle, C., & Clarke, S. J. (2008) · Clinical Colorectal Cancer · doi:10.3816/ccc.2008.n.044 · Cited by 103
Shi, H. Y. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i7.1421 · Cited by 101
Mochizuki, H., Matsubara, A., Teishima, J., Mutaguchi, K., Yasumoto, H., Dahiya, R., Usui, T., & Kamiya, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.013 · Cited by 99
Reichle, A., Bross, K., VOGT, T. M., Bataille, F., Wild, P. J., Berand, A., Krause, S. W., & Andreesen, R. (2004) · Cancer · doi:10.1002/cncr.20574 · Cited by 99
Increased Expression and Secretion of Interleukin-6 in Patients with Barrett’s Esophagus
Dvorakova, K., Payne, C., Ramsey, L., Holubec, H., Sampliner, R., Dominguez, J. A., Dvořák, B., Bernstein, H., Bernstein, C., Prasad, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0437-03 · Cited by 98
Expression of NF‐κB in prostate cancer lymph node metastases
A, H. I., Lessard, L., Mes‐Masson, A., & Fred Saad, C. (2003) · The Prostate · doi:10.1002/pros.10335 · Cited by 97
Kimura, S., Kitadai, Y., Tanaka, S., Kuwai, T., Hihara, J., Yoshida, K., Toge, T., & Chayama, K. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.035 · Cited by 97
Rajnakova, A., Moochhala, S., Goh, P. M. Y., & Ngoi, S. S. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00645-0 · Cited by 97
Gu, Z., Li, J., Li, M., Gu, J., Shi, X., Ke, Y., & Chen, K. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50018.x · Cited by 96
Dassoulas, K., Gazouli, M., Rizos, S., Theodoropoulos, G. E., Christoni, Z., Nikiteas, N. I., & Karakitsos, P. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20495 · Cited by 96
Meteoğlu, İ., Erdoğdu, İ. H., Meydan, N., Erkuş, M., & Barutça, S. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-53 · Cited by 93
Cancer stem cells: Models, mechanisms and implications for improved treatment
Zhou, J., & Zhang, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5953 · Cited by 92
Metalloproteinase expression and prognosis in soft tissue sarcomas
Benassi, M. S., Gamberi, G., Magagnoli, G., Molendini, L., Ragazzini, P., Merli, M., Chiesa, F., Balladelli, A., Manfrini, M., Bertoni, F., et al. (2001) · Annals of Oncology · doi:10.1023/a:1008318614461 · Cited by 86
Nitric Oxide Synthase Activity in Human Lung Cancer
Fujimoto, H., Ando, Y., Yamashita, T., Terazaki, H., Tanaka, Y., Sasaki, J., Matsumoto, M., Suga, M., & Ando, M. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00348.x · Cited by 85
5-Lipoxygenase, a Marker for Early Pancreatic Intraepithelial Neoplastic Lesions
Hennig, R., Grippo, P. J., Ding, X.-Z., Rao, S. M., Büchler, M. W., Friess, H., Talamonti, M., Bell, R. H., & Adrian, T. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4090 · Cited by 82
Cyclooxygenase‐2 (cox‐2) expression is an independent predictor of prostate cancer recurrence
Cohen, B. L., Gomez, P., Omori, Y., DUNCAN, R. C., Civantos, F., Soloway, M. S., Lokeshwar, V. B., & Lokeshwar, B. L. (2006) · International Journal of Cancer · doi:10.1002/ijc.21749 · Cited by 81
Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S., Pozzi, S., Frassoni, F., Fassina, G., Soverini, S., Albini, A., & Ferrari, N. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0132 · Cited by 81
Cabıoğlu, N., Şahin, A. A., Morandi, P., Meric‐Bernstam, F., Islam, R., Lin, H. Y., Bucana, C. D., Gonzalez-Angulo, A. M., Hortobágyi, G. N., & Cristofanilli, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn740 · Cited by 80
Seymour, J. F., Talpaz, M., Hagemeister, F. B., Cabanillas, F., & Kurzrock, R. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00352-x · Cited by 80
c‐Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome
Valnet‐Rabier, M., Challier, B., Thiebault, S., Angonin, R., Margueritte, G., Mougin, C., Kantelip, B. M., Deconinck, É., Cahn, J.-Y. Y., & Fest, T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05378.x · Cited by 79
Cyclooxygenase-2 is Overexpressed in Chronic Pancreatitis
Schlosser, W., Schlosser, S., Ramadani, M., Gansauge, F., Gansauge, S., & Beger, H. G. (2002) · Pancreas · doi:10.1097/00006676-200207000-00008 · Cited by 79
Predictive value of interleukin-6 and neopterin in patients with multiple myeloma.
Reibnegger, G. J., Krainer, M., Herold, M., Ludwig, H., WACHTER, H., & Huber, H. P. (1991) · PubMed · Cited by 78
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma
Tang, T. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i13.1896 · Cited by 77
Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1
Arai, J. A., Yasukawa, M., Yakushijin, Y., Miyazaki, T., & Fujita, S. (2000) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2000.90147.x · Cited by 77
The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance?
Heidland, A., Klassen, A., Rutkowski, P., & Bahner, U. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.s10.s102 · Cited by 70
Sakata, K., Satoh, M., Someya, M., Asanuma, H., Nagakura, H., Oouchi, A., Nakata, K., Kogawa, K., Koito, K., Hareyama, M., et al. (2004) · Cancer · doi:10.1002/cncr.11905 · Cited by 70
Seo, S. S., Song, Y. S., Kang, D., Park, I. A., Bang, Y. J., Kang, S. B., & Lee, H. P. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.055 · Cited by 69
Kubo, F., Ueno, S., Hiwatashi, K., Sakoda, M., Kawaida, K., Nuruki, K., & Aikou, T. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.07.015 · Cited by 69
Jiang, W. G., Douglas-Jones, A. G., & Mansel, R. E. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.10.005 · Cited by 68
Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer
Klotz, T., Bloch, W., Jacobs, G., Niggemann, S., Engelmann, U. H., & Addicks, K. (1999) · Urology · doi:10.1016/s0090-4295(99)00212-5 · Cited by 67
Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance
Höchtlen-Vollmar, W., Menzel, G., Bartl, R., Lamerz, R., Wick, M. W., & Seidel, D. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02007.x · Cited by 67
The CXCR4/CXCL12 axis in endometrial cancer
Gelmini, S., Mangoni, M., Castiglione, F., Beltrami, C., Pieralli, A., Andersson, K. L., Fambrini, M., Taddei, G. L., Serio, M., & Orlando, C. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9240-4 · Cited by 65
Tjiu, J., Liao, Y., Lin, S., Huang, Y., Tsai, W.-L., Chu, C., Kuo, M., & Jee, S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700191 · Cited by 65
Natarajan, R. D., Esworthy, R. S., Bai, W., Gu, J., Wilczynski, S. P., & Nadler, J. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3990 · Cited by 65
Fagotti, A., Ferrandina, G., Fanfani, F., Legge, F., Lauriola, L., Gessi, M., Castelli, M. P., Barbieri, F., Minelli, L., & Scambia, G. (2004) · Human Reproduction · doi:10.1093/humrep/deh054 · Cited by 64
Izzo, J. G., Correa, A. M., Wu, T., Malhotra, U., Chao, C., Luthra, R., Ensor, J., Dekovich, A. A., Liao, Z. X., Hittelman, W. N., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0351 · Cited by 64
Self-citationInterleukin‐6 Levels in Colorectal Cancer Tissues
Komoda, H., Tanaka, Y., HONDA, M., Matsuo, Y., Hazama, K., & Takao, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900489 · Cited by 63
Haraguchi, M., Komuta, K., Akashi, A., Matsuzaki, S., Furui, J., & Kanematsu, T. (2002) · Oncology Reports · doi:10.3892/or.9.1.159 · Cited by 63
COX-2 Expression in Invasive Breast Cancer: Correlation With Prognostic Parameters and Outcome
Nassar, A., Radhakrishnan, A., Cabrero, I. A., Cotsonis, G., & Cohen, C. (2007) · Applied immunohistochemistry & molecular morphology · doi:10.1097/01.pai.0000213130.63417.b3 · Cited by 62
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
Hewamana, S., Lin, T. T., Rowntree, C. J., Karunanithi, K., Pratt, G., Hills, R. K., Fegan, C., Brennan, P., & Pepper, C. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1114 · Cited by 62
Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm, H., Rubin, I., Kruse, A., Brændstrup, O., Schmidt, K. F., Skriver, E. B., & Lauritzen, M. (2003) · PubMed · Cited by 61
Guo, R., Qiao, Y., Zhou, Y., Li, L., Shi, H., & Chen, K. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02306.x · Cited by 61
Terada, H., Urano, T., & Konno, H. (2005) · European Surgical Research · doi:10.1159/000085964 · Cited by 60
新島, 光., Yamaguchi, T., Ishihara, T., Hara, T., Kato, K., Kondo, F., & Saisho, H. (2002) · Cancer · doi:10.1002/cncr.10358 · Cited by 60
Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung, Y., Chaen, Y.-L., & Hsu, C.-P. (2006) · PubMed · Cited by 59
Bhojani, M. S., Chen, G., Ross, B. D., Beer, D. G., & Rehemtulla, A. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2188 · Cited by 56
H. Ito, C. M. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750024959 · Cited by 56
Ferrandina, G., Lauriola, L., Zannoni, G. F., Distefano, M., Legge, F., Salutari, V., Gessi, M., Maggiano, N., Scambia, G., & Ranelletti, F. O. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600578 · Cited by 55
Woo, S. U., Bae, J. W., Kim, C. H., Lee, J. B., & Koo, B. W. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9595-1 · Cited by 55
Widera, D., Kaus, A., Kaltschmidt, C., & Kaltschmidt, B. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00208.x · Cited by 55
Dikov, M. M., Oyama, T., Cheng, P., Takahashi, T., Takahashi, K., Sepetavec, T., Edwards, B., Adachi, Y., Nadaf, S., Daniel, T., et al. (2001) · PubMed · Cited by 54
Wagner, P. L., Moo, T.-A. S., Arora, N., Liu, Y., Zarnegar, R., Scognamiglio, T., & Fahey, T. J. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0064-2 · Cited by 54
Korkolopoulou, P. A., Levidou, G., Saetta, A. A., El-Habr, E. A., Eftichiadis, C., Demenagas, P., Thymara, I., Xiromeritis, K., Boviatsis, E. I., Thomas-Tsagli, E., et al. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.01.020 · Cited by 51
The role of VEGF-C staining in predicting regional metastasis in melanoma
Boone, B., Blokx, W. A. M., Bacquer, D. D., Lambert, J., Ruiter, D. J., & Brochez, L. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0641-6 · Cited by 51
Prognostic Significance of Cyclooxygenase-2 in Oropharyngeal Squamous Cell Carcinoma
Chang, B. W., Kim, D. H., Kowalski, D. P., Burleson, J. A., Son, Y. H., Wilson, L. D., & Haffty, B. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0354 · Cited by 49
Clinical Significance of Cell Cycle–and Apoptosis-Related Markers in Biliary Tract Cancer
Karamitopoulou, E., Tornillo, L., Zlobec, I., Cioccari, L., Carafa, V., Borner, M., Schaffner, T. J., Brunner, T., Diamantis, I. D., Zimmermann, A., et al. (2008) · American Journal of Clinical Pathology · doi:10.1309/ajcp35fdcavanwmm · Cited by 46
Tang, H., Wang, J., Bai, F., Zhai, H., Gao, J., Hong, L., Xie, H., Zhang, F., Lan, M., Yao, W., et al. (2008) · Cancer Investigation · doi:10.1080/07357900701519279 · Cited by 43
Hewamana, S., Lin, T. T., Jenkins, C., Burnett, A. K., Jordan, C. T., Fegan, C., Brennan, P., Rowntree, C. J., & Pepper, C. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1673 · Cited by 43
Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma
Li, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1862 · Cited by 42
Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma.
Yamanaka, N., Sasaki, N., Tasaki, A., Nakashima, H., Kubo, M., Morisaki, T., Noshirο, H., Yao, T., Tsuneyoshi, M., Tanaka, M., et al. (2004) · PubMed · Cited by 42
Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma.
Faronato, M., Muzzonigro, G., Milanese, G., Menna, C., Bonfigli, A. R., Catalano, A., & Procopio, A. D. (2007) · PubMed · doi:10.14670/hh-22.1109 · Cited by 41
Takatori, H., Natsugoe, S., Okumura, H., Matsumoto, M., Uchikado, Y., Setoyama, T., Sasaki, K., Tamotsu, K., Owaki, T., Ishigami, S., et al. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.04.011 · Cited by 40
Gao, K., Dai, D. L., Martinka, M., & Li, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4402 · Cited by 39
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy
Wang, M., Sun, L., Qian, J., Han, X., Zhang, L., Lin, P., Cai, Z., & Yi, Q. (2009) · Leukemia · doi:10.1038/leu.2009.19 · Cited by 37
Guo, X., Chen, Y., Xu, Z., Xu, Z., Qian, Y., & Yu, X. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp004 · Cited by 36
Overexpression of cyclooxygenase‐2 in multiple myeloma: Association with reduced survival
Çetın, M., Buyukberber, S., Demir, M., Sarı, İ., Sari, I., Denız, K., Eser, B., Altuntaş, F., Camcı, C., Öztürk, A., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20460 · Cited by 35
Haffty, B. G., Yang, Q., Moran, M. S., Tan, A. R., & Reiß, M. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.063 · Cited by 33
Nakamoto, R. H., Uetake, H., Iida, S., Kolev, Y., Soumaoro, L. T., Takagi, Y., Yasuno, M., & Sugihara, K. (2007) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hym080 · Cited by 33
Romano, M., Cuomo, A., Tuccillo, C., Salerno, R., Rocco, A., Staibano, S., Mascolo, M., Sciaudone, G., Mucherino, C., Giuliani, A., et al. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0807-8 · Cited by 32
Lü, S., Yu, G., Zhu, Y., & Archer, M. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21142 · Cited by 32
Lee, K.-J., Kim, H.-A., Kim, P.-H., Lee, H., Ma, K.-R., Park, J. H., Kim, D. J., & Hahn, J.-H. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.68 · Cited by 31
Kuramoto, K., Sakai, A., Shigemasa, K., Takimoto, Y., Asaoku, H., Tsujimoto, T., Oda, K., Kimura, A., Uesaka, T., Watanabe, H., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03253.x · Cited by 31
Nuclear factor-κB as a predictor of treatment response in breast cancer
Garg, A. K., Hortobágyi, G. N., Aggarwal, B. B., Şahin, A. A., & Buchholz, T. A. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00001 · Cited by 30
Self-citationYang, G.-Z., Li, L., Ding, H.-Y., & Zhou, J. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.09.002 · Cited by 30
Combined Prognostic Value of Both RelA and IκB-α Expression in Human Non–Small Cell Lung Cancer
Zhang, D., Jin, X., Wang, F., Wang, S., Deng, C., Gao, Z., & Guo, C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9560-z · Cited by 27
Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer
Sackett, M. K., Bairati, I., Meyer, F., Jobin, É., Lussier, S., Fortin, A., Gélinas, M., Nabid, A., Brochet, F., & Têtu, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2028 · Cited by 27
Izzo, J. G., Malhotra, U., Wu, T., Luthra, R., Correa, A. M., Swisher, S. G., Hofstetter, W. L., Chao, K. S. C., Hung, M., & Ajani, J. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1083 · Cited by 27
The ubiquitin‐proteasome pathway and enhanced activity of NF‐κB in gastric carcinoma
Wu, L., Pu, Z., Feng, J., Li, G., Zheng, Z., & Wenlv, S. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20952 · Cited by 26
Liu, B., Ren, Z., Shi, Y., Guan, C., Pan, Z., & Zong, Z. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31817fd3fa · Cited by 26
Shim, S. J., Yang, W., Shin, E., Koom, W. S., Kim, Y. B., Cho, J., Suh, C., Kim, J. H., & Kim, G. E. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.1387 · Cited by 26
Vanasse, G., Winn, R., Rodov, S., Zieske, A., Li, J. T., Tupper, J., Tang, J., Raines, E., Peters, M., Yeung, K.-Y., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.620.2.11 · Cited by 26
Zhang, B., Zhao, W., Zhou, W., Yu, W.-S., Yu, J., & Li, S. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2007.10.016 · Cited by 25
Cressey, R., Pimpa, S., Tontrong, W., Wattananupong, O., & Leartprasertsuke, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.023 · Cited by 24
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
Tinguely, M., Vallet, S., Jenni, B., Witzens‐Harig, M., Mechtersheimer, G., Ho, A. D., Goldschmidt, H., Jäger, D., Boccadoro, M., & Ladetto, M. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11467 · Cited by 23
Kato, H., Kinoshita, T., Suzuki, S., Nagasaka, T., Murate, T., Saito, H., & Hotta, T. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.444983.x · Cited by 23
Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients
El-Salahy, E. M. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00382-x · Cited by 21
Coordinated Upregulation of COX-2 and NF-κB Is a Steady Feature of Laryngeal Carcinogenesis
Kourelis, K. G., Sotiropoulou‐Bonikou, G., Vandoros, G. P., Repanti, M., Varakis, I., & Goumas, P. (2007) · ORL · doi:10.1159/000099229 · Cited by 18
Ling, F. C., Baldus, S. E., Khochfar, J., Xi, H., Neiss, S., Brabender, J., Metzger, R., Drebber, U., Dienes, H. P., Bollschweiler, E., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02576.x · Cited by 18
Hbibi, A. T., Lagorce, C., Wind, P., Spano, J., Guetz, G. D., Milano, G. A., Benamouzig, R., Rixe, O., Morère, J., Breau, J. L., et al. (2008) · Cancer Biomarkers · doi:10.3233/cbm-2008-4204 · Cited by 17
Yamamoto, M., Fukushima, T., Hayashi, S., Ikeda, K., Tsugu, H., Kimura, H., Soma, G., & Tomonaga, M. (2000) · PubMed · Cited by 17
Production of Interleukin-6 in High Grade B Lymphomas
Emilie, D., Devergne, O., Raphaël, M., et al. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77633-5_45 · Cited by 14
Hayashi, H., Kuwahara, M., FUJISAKI, N., Furihata, M., Ohtsuki, Y., & Kagawa, S. (2001) · Oncology Reports · doi:10.3892/or.8.6.1275 · Cited by 14
Houldsworth, J., Petlakh, M., Olshen, A. B., & Chaganti, R. S. K. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802428369 · Cited by 14
Abe, A., Fukui, H., Fujii, S., Fujita, M., Mukawa, K., Ichikawa, K., Tomita, S., Ono, Y., Imai, Y., Imura, J., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04778.x · Cited by 12
[Changes of serum il-6 and CRP after chemotherapy in patients with ovarian carcinoma].
Zakrzewska, I., & Poznański, J. (2001) · PubMed · Cited by 12
Hu, Z., Wen, J., Shen, M., & Liu, Y. (2006) · PubMed · Cited by 11
Gasparian, A. V., Fedorova, M. D., & Kisseljov, F. L. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907080068 · Cited by 10
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Self-citationCox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9235-2 · Cited by 806
Self-citationTargeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Multifaceted roles of PGE2 in inflammation and cancer
Nakanishi, M., & Rosenberg, D. W. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0342-8 · Cited by 591
Metadata
- Authors
- Aggarwal, B. B., & Gehlot, P.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 9
- Issue
- 4
- Pages
- 351-369
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2128609469
- Cited by
- 405
- References
- 195
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.